Joji Iida

1.7k total citations
32 papers, 1.5k citations indexed

About

Joji Iida is a scholar working on Immunology and Allergy, Cell Biology and Molecular Biology. According to data from OpenAlex, Joji Iida has authored 32 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology and Allergy, 13 papers in Cell Biology and 12 papers in Molecular Biology. Recurrent topics in Joji Iida's work include Cell Adhesion Molecules Research (18 papers), Proteoglycans and glycosaminoglycans research (12 papers) and Glycosylation and Glycoproteins Research (6 papers). Joji Iida is often cited by papers focused on Cell Adhesion Molecules Research (18 papers), Proteoglycans and glycosaminoglycans research (12 papers) and Glycosylation and Glycoproteins Research (6 papers). Joji Iida collaborates with scholars based in United States, Japan and Netherlands. Joji Iida's co-authors include James B. McCarthy, Leo T. Furcht, Melanie A. Simpson, Alexandra M.L. Meijne, Christopher M. Wilson, Matt A. Price, Duanqing Pei, Cheryl L. Neudauer, Kelli M. Bullard and Ed Roos and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Cell Biology and PLoS ONE.

In The Last Decade

Joji Iida

32 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joji Iida United States 21 781 594 362 288 278 32 1.5k
Staffan Johansson Sweden 23 676 0.9× 491 0.8× 727 2.0× 174 0.6× 273 1.0× 36 1.6k
Elena Tanghetti Italy 16 810 1.0× 266 0.4× 298 0.8× 233 0.8× 193 0.7× 23 1.3k
Rabia Sadir France 22 695 0.9× 652 1.1× 217 0.6× 399 1.4× 83 0.3× 28 1.3k
David J. Mahoney United Kingdom 20 1.1k 1.4× 867 1.5× 317 0.9× 189 0.7× 136 0.5× 22 2.1k
Cornelia Tölg Canada 21 1.3k 1.7× 1.3k 2.2× 432 1.2× 403 1.4× 235 0.8× 38 2.2k
L T Furcht United States 18 471 0.6× 395 0.7× 706 2.0× 226 0.8× 306 1.1× 27 1.2k
Bianca R. Tomasini-Johansson United States 17 461 0.6× 425 0.7× 459 1.3× 96 0.3× 209 0.8× 25 1.1k
Shelesa A. Brew United States 22 522 0.7× 359 0.6× 550 1.5× 123 0.4× 404 1.5× 30 1.2k
Stephan Niland Germany 22 895 1.1× 415 0.7× 378 1.0× 448 1.6× 396 1.4× 42 1.9k
Anne Kultti Finland 13 991 1.3× 901 1.5× 153 0.4× 787 2.7× 315 1.1× 15 2.0k

Countries citing papers authored by Joji Iida

Since Specialization
Citations

This map shows the geographic impact of Joji Iida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joji Iida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joji Iida more than expected).

Fields of papers citing papers by Joji Iida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joji Iida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joji Iida. The network helps show where Joji Iida may publish in the future.

Co-authorship network of co-authors of Joji Iida

This figure shows the co-authorship network connecting the top 25 collaborators of Joji Iida. A scholar is included among the top collaborators of Joji Iida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joji Iida. Joji Iida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Iida, Joji, et al.. (2016). Inhibition of cancer cell growth by ruthenium complexes. Journal of Translational Medicine. 14(1). 48–48. 28 indexed citations
2.
Iida, Joji, Rachel E. Ellsworth, Yasuhiro Katagiri, et al.. (2014). Role for chondroitin sulfate glycosaminoglycan in NEDD9-mediated breast cancer cell growth. Experimental Cell Research. 330(2). 358–370. 51 indexed citations
3.
Iida, Joji, Richard I. Somiari, Stella Somiari, et al.. (2014). DNA Aptamers against Exon v10 of CD44 Inhibit Breast Cancer Cell Migration. PLoS ONE. 9(2). e88712–e88712. 39 indexed citations
4.
Iida, Joji, Yaqin Chen, Stella Somiari, et al.. (2012). FH535 Inhibited Migration and Growth of Breast Cancer Cells. PLoS ONE. 7(9). e44418–e44418. 29 indexed citations
5.
Lee, Peter K., et al.. (2009). Inhibition of hyaluronan synthases decreases matrix metalloproteinase-7 (MMP-7) expression and activity. Surgery. 145(3). 322–329. 14 indexed citations
6.
Goda, Seiji, et al.. (2009). Enamel Matrix Derivative Protein Stimulated Wound Healing via Phosphoinositide 3‐Kinase. Journal of Periodontology. 80(10). 1631–1637. 6 indexed citations
7.
Iida, Joji & James B. McCarthy. (2007). Expression of collagenase-1 (MMP-1) promotes melanoma growth through the generation of active transforming growth factor-β. Melanoma Research. 17(4). 205–213. 38 indexed citations
8.
Goda, Seiji, Hiroshi Inoue, Hisanori Umehara, et al.. (2006). Matrix Metalloproteinase-1 Produced by Human CXCL12-Stimulated Natural Killer Cells. American Journal Of Pathology. 169(2). 445–458. 38 indexed citations
9.
Iida, Joji, Matt A. Price, Christopher M. Wilson, et al.. (2004). Membrane Type-1 Matrix Metalloproteinase Promotes Human Melanoma Invasion and Growth. Journal of Investigative Dermatology. 122(1). 167–176. 59 indexed citations
10.
Iida, Joji, et al.. (2004). Hyaluronan mediates adhesion of metastatic colon carcinoma cells1. Journal of Surgical Research. 122(1). 70–74. 36 indexed citations
11.
Iida, Joji, Duanqing Pei, Tiebang Kang, et al.. (2001). Melanoma Chondroitin Sulfate Proteoglycan Regulates Matrix Metalloproteinase-dependent Human Melanoma Invasion into Type I Collagen. Journal of Biological Chemistry. 276(22). 18786–18794. 85 indexed citations
12.
Eisenmann, Kathryn M., James B. McCarthy, Melanie A. Simpson, et al.. (1999). Melanoma chondroitin sulphate proteoglycan regulates cell spreading through Cdc42, Ack-1 and p130cas. Nature Cell Biology. 1(8). 507–513. 171 indexed citations
13.
Iida, Joji, Alexandra M.L. Meijne, Theodore R. Oegema, et al.. (1998). A Role of Chondroitin Sulfate Glycosaminoglycan Binding Site in α4β1 Integrin-mediated Melanoma Cell Adhesion. Journal of Biological Chemistry. 273(10). 5955–5962. 96 indexed citations
14.
McCarthy, James B., et al.. (1996). Cell adhesion to collagenous matrices. Biopolymers. 40(4). 371–381. 35 indexed citations
15.
Iida, Joji, et al.. (1996). Cell surface chondroitin sulfate proteoglycans in tumor cell adhesion, motility and invasion. Seminars in Cancer Biology. 7(3). 155–162. 71 indexed citations
16.
Iida, Joji, Chiaki Ishihara, Kyosuke Kitoh, et al.. (1990). Prophylactic activity of dihydro-heptaprenol, a synthetic polyprenol derivative, against Sendai virus infection in mice. Vaccine. 8(4). 376–380. 9 indexed citations
17.
Iida, Joji, Ikuo Saiki, Chiaki Ishihara, & Ichiro Azuma. (1989). Protective activity of recombinant cytokines against Sendai virus and herpes simplex virus (HSV) infections in mice. Vaccine. 7(3). 229–233. 20 indexed citations
18.
Iida, Joji, Norio Nishi, Ikuo Saiki, et al.. (1989). Macrophage activation and host augmentation against Sendai or herpes simplex virus (HSV) infections with synthetic polypeptides in mice. International Journal of Immunopharmacology. 11(3). 249–258. 3 indexed citations
19.
Saiki, Ikuo, Hiroaki Maeda, Takuma Sakurai, et al.. (1989). Induction of an endogenous tumor necrosis factor in mice by murine recombinant interferon-? combined with a lipid A subunit analog (GLA-60) of low toxicity. Cancer Immunology Immunotherapy. 29(2). 101–8. 16 indexed citations
20.
Iida, Joji, et al.. (1986). Adjuvant and antitumour activities of synthetic lipid A analogues. Vaccine. 4(1). 21–24. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026